Imagine if Hurricanes Harvey and Irma were predicted the same way CVD is predicted!

Imagine if hurricanes Harvey and Irma were predicted the same way CVD is predicted today: an estimated 10-year risk prediction!

Imagine if the weatherman says there is a 7.5% chance of a category 5 hurricane in the next 10 years. 

Do you think people would take immediate preventive actions like boarding up their windows, buying hurricane supplies, or even changing their daily routines???

Most likely not, because long term predictions do not trigger immediate preventive actions. This is why Cardiology needs a short-term predictor (preferably 6-12 month forecast), and we (SHAPE and collaborators) are going to create it.

Visit http://shapesociety.org/the-first-machine-learning-heart-attack-forecast-symposium
to find out how we are using machine learning and existing cohorts to tackle this problem.

Machine Learning Vulnerable Patient -SHAPE Sym.png

heart_hurricane.jpgHurricane_Irma_4-5_September_GOES_Floater_Rain.gif

Join thousands of doctors, nurses, and other cardiovascular professionals at the upcoming 2017 scientific sessions of the American Heart Association and learn about SHAPE’s initiative to develop a short-term CVD risk predictor.

Make sure to attend the SHAPE Symposium (Monday, November 13, 2017, 7-9PM), and also participate in the following AHA session where Dr. Morteza Naghavi, the founder of SHAPE and the leader of “Machine Learning Vulnerable Patient”, presents the following breakthrough findings:

AHA 2017, November 13, 3:40 PM, Orange County Convention Center, Anaheim, California. 

Monday, November 13, 2017, 3:40 pm Machine Learning Outperformed ACC/AHA Pooled Cohort Equations Risk Calculator for Detection of High-Risk Asymptomatic Individuals and Recommending Treatment for Prevention of Cardiovascular Events in the Multi-Ethnic Study of Atherosclerosis (MESA)

Ioannis A. Kakadiaris, Ph.D.1, Michalis Vrigkas, Ph.D.1, Matthew Budoff, M.D.2, Albert A. Yen, M.D.3, Morteza Naghavi, M.D.4

Institutional Affiliations [1: Computational Biomedicine Lab, University of Houston, Houston, TX, USA; 2: Division of Cardiology, Los Angeles Biomedical Research at Harbor-UCLA Medical Center, Torrance, CA, USA; 3: MEDITEX (Medical Innovations in Texas), Houston, TX, USA; 4: Society for Heart Attack Prevention and Eradication, Houston, TX, USA]

Corresponding Author:

Dr._Naghvi_Blue_tie_sm.jpg

Morteza Naghavi, M.D.
Society for Heart Attack Prevention and Eradication (SHAPE), Houston, TX 77024, USA
(+1) 877-SHAPE11 (877-742-7311)
mn@vp.org 

LATEST SCIENTIFIC UPDATES

Enhance your patient care with the new office-based vascular function test.

Sign Up for our Webinar Series

Why Should We Measure Endothelial Function?